Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed Apr 1, 2016
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-04-01+50,000→ 50,000 totalExercise: $10.74Exp: 2026-04-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option vests in 4 equal, annual installments, beginning on April 1, 2017.